| |
Persistent paina
| |
|---|
| |
N (%)
|
P-value
|
|---|
|
Surgery (n = 1043)
| | |
|
Radical (n = 224)
|
27 (12.1)
|
0.693
|
|
Conservative (n = 819)
|
91 (11.1)
| |
|
Axillary treatmentb (n = 983)
| |
<0.01
|
|
Only SLNB (n = 268)
|
18 (6.7)
| |
|
ALND (n = 715)
|
98 (13.7)
| |
|
Neoadjuvant therapy (n = 1045)
| |
0.090
|
|
No (n = 936)
|
111 (11.9)
| |
|
Yes (n = 109)
|
7 (6.4)
| |
|
Adjuvant therapy post-surgery (n = 1039)
| |
1
|
|
No (n = 26)
|
3 (11.5)
| |
|
Yes (n = 1013)
|
115 (11.4)
| |
|
Chemotherapy (n = 1018)
| |
<0.01
|
|
No (n = 513)
|
43 (8.4)
| |
|
Yes (n = 505)
|
73 (14.5)
| |
|
Radiotherapy (n = 998)
| |
0.457
|
|
No (n = 155)
|
15 (9.7)
| |
|
Yes (n = 843)
|
99 (11.7)
| |
|
Hormone therapy (n = 1019)
| |
0.328
|
|
No (n = 219)
|
29 (13.2)
| |
|
Yes (n = 800)
|
87 (10.9)
| |
|
Her2 treatment (n = 1028)
| |
0.790
|
|
No (n = 979)
|
112 (11.4)
| |
|
Yes (n = 49)
|
5 (10.2)
| |
- aPercentages are computed as follows: number of women with persistent pain divided by the total number of women for each category
- bSLNB: sentinel lymph node biopsy. In this category only women with SLNB performed were included. ALND: axillary lymph node dissection. This category includes women with only ALND performed and women with SLNB and ALND
